AIIMS Nagpur Secures ₹30 Crore for Advanced BSL-3 Laboratory
The National Centre for Disease Control allocates significant funding to enhance local pathogen research capabilities.
AIIMS Nagpur receives ₹30 crore from NCDC for a BSL-3 lab.
The new facility will enhance local healthcare's ability to manage high-risk pathogens.
This initiative aims to reduce reliance on external testing centers.
The National Centre for Disease Control (NCDC) has approved a substantial funding of ₹30 crore for AIIMS Nagpur to establish a state-of-the-art BSL-3 laboratory. This facility is expected to significantly bolster the region's healthcare infrastructure by enabling the isolation and study of high-risk pathogens, which is crucial given the rising threats posed by emerging infectious diseases.
The establishment of the BSL-3 laboratory comes at a time when central India faces increasing encounters with zoonotic pathogens due to environmental changes and deforestation. This advanced laboratory will feature high-containment capabilities, including negative air pressure and HEPA filtration systems, allowing specialists to safely handle dangerous agents. As a result, local healthcare providers will benefit from quicker diagnostic confirmations during outbreaks, enhancing their response capabilities.
In addition to the BSL-3 lab, AIIMS Nagpur is set to upgrade its existing Virus Research and Diagnostic Laboratory into an Infectious Disease Research and Diagnostic Laboratory. This transformation will expand diagnostic capabilities to cover bacteriology, mycology, and parasitology, thereby improving syndromic and genomic surveillance. Such advancements are vital for identifying unusual illness patterns and tracking viral mutations, which can help in controlling potential outbreaks before they escalate.
Historically, samples suspected of containing dangerous pathogens were sent to the National Institute of Virology in Pune, leading to delays in public health responses. The new laboratory at AIIMS Nagpur will streamline this process, ensuring timely diagnostic results and effective patient management. With AIIMS Nagpur already setting quality standards across over 250 testing laboratories, local clinicians can expect improved efficiency in identifying respiratory and hemorrhagic pathogens, ultimately enhancing hospital infection control measures.
Looking ahead, the establishment of the BSL-3 laboratory is a significant step towards strengthening the healthcare framework in central India. It will not only facilitate advanced research but also prepare local healthcare systems for future challenges posed by infectious diseases. The timeline for the laboratory's operational readiness will be closely monitored as AIIMS Nagpur continues to enhance its capabilities.
